191 related articles for article (PubMed ID: 32278711)
1. Structure-based design and synthesis of novel furan-diketopiperazine-type derivatives as potent microtubule inhibitors for treating cancer.
Ding Z; Li F; Zhong C; Li F; Liu Y; Wang S; Zhao J; Li W
Bioorg Med Chem; 2020 May; 28(10):115435. PubMed ID: 32278711
[TBL] [Abstract][Full Text] [Related]
2. Design and Synthesis of Novel Phenylahistin Derivatives Based on Co-Crystal Structures as Potent Microtubule Inhibitors for Anti-Cancer Therapy.
Ding Z; Li F; Xie L; Gu M; Li C; Liu C; Peng C; Li W
Mar Drugs; 2022 Nov; 20(12):. PubMed ID: 36547899
[TBL] [Abstract][Full Text] [Related]
3. Development of novel phenoxy-diketopiperazine-type plinabulin derivatives as potent antimicrotubule agents based on the co-crystal structure.
Ding Z; Ma M; Zhong C; Wang S; Fu Z; Hou Y; Liu Y; Zhong L; Chu Y; Li F; Song C; Wang Y; Yang J; Li W
Bioorg Med Chem; 2020 Jan; 28(1):115186. PubMed ID: 31759826
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationship study of antimicrotubule agents phenylahistin derivatives with a didehydropiperazine-2,5-dione structure.
Yamazaki Y; Tanaka K; Nicholson B; Deyanat-Yazdi G; Potts B; Yoshida T; Oda A; Kitagawa T; Orikasa S; Kiso Y; Yasui H; Akamatsu M; Chinen T; Usui T; Shinozaki Y; Yakushiji F; Miller BR; Neuteboom S; Palladino M; Kanoh K; Lloyd GK; Hayashi Y
J Med Chem; 2012 Feb; 55(3):1056-71. PubMed ID: 22185476
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and cytotoxic activities of novel 2,5-diketopiperazine derivatives.
Liao SR; Qin XC; Wang Z; Li D; Xu L; Li JS; Tu ZC; Liu Y
Eur J Med Chem; 2016 Oct; 121():500-509. PubMed ID: 27318124
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, in vitro and in vivo biological evaluation of 2-amino-3-aroylbenzo[b]furan derivatives as highly potent tubulin polymerization inhibitors.
Oliva P; Romagnoli R; Manfredini S; Brancale A; Ferla S; Hamel E; Ronca R; Maccarinelli F; Giacomini A; Rruga F; Mariotto E; Viola G; Bortolozzi R
Eur J Med Chem; 2020 Aug; 200():112448. PubMed ID: 32417696
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and structure-activity relationship study of novel plinabulin derivatives as anti-tumor agents based on the co-crystal structure.
Wang S; Zhong C; Li F; Ding Z; Tang Y; Li W
Mol Divers; 2024 Apr; ():. PubMed ID: 38652366
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of anti-pancreatic cancer activity of plinabulin derivatives based on the co-crystal structure.
Fu Z; Hou Y; Ji C; Ma M; Tian Z; Deng M; Zhong L; Chu Y; Li W
Bioorg Med Chem; 2018 May; 26(8):2061-2072. PubMed ID: 29571653
[TBL] [Abstract][Full Text] [Related]
9. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition.
Romagnoli R; Kimatrai Salvador M; Schiaffino Ortega S; Baraldi PG; Oliva P; Baraldi S; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Balzarini J; Liekens S; Mattiuzzo E; Basso G; Viola G
Eur J Med Chem; 2018 Jan; 143():683-698. PubMed ID: 29220790
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of New Arylidene 2,5-Diketopiperazines and Evaluation of their Anti-Acetylcholinesterase, Anti-xanthine Oxidase, Anti-diabetic and Cytotoxic Activities.
Belkacem MA; Jannet HB; Ferhout H; Mzali L; Bouajila J
Med Chem; 2017; 13(8):744-752. PubMed ID: 28480832
[TBL] [Abstract][Full Text] [Related]
11. Discovery of 1,3-Disubstituted 2,5-Diketopiperazine Derivatives as Potent Class I HDACs Inhibitors.
Gong G; Qi J; Lv Y; Dong S; Cao C; Li D; Zhao R; Li Z; Chen X
Chem Pharm Bull (Tokyo); 2020; 68(5):466-472. PubMed ID: 32378544
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationships of benzophenone-bearing diketopiperazine-type anti-microtubule agents.
Yamazaki Y; Sumikura M; Masuda Y; Hayashi Y; Yasui H; Kiso Y; Chinen T; Usui T; Yakushiji F; Potts B; Neuteboom S; Palladino M; Lloyd GK; Hayashi Y
Bioorg Med Chem; 2012 Jul; 20(14):4279-89. PubMed ID: 22727370
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, In Vitro Antitumor Activity and Molecular Mechanism of Novel Furan Derivatives and their Precursors.
Lu D; Zhou Y; Li Q; Luo J; Jiang Q; He B; Tang Q
Anticancer Agents Med Chem; 2020; 20(12):1475-1486. PubMed ID: 32329695
[TBL] [Abstract][Full Text] [Related]
14. Furan-2-carboxamide derivative, a novel microtubule stabilizing agent induces mitotic arrest and potentiates apoptosis in cancer cells.
Shwetha B; Sudhanva MS; Jagadeesha GS; Thimmegowda NR; Hamse VK; Sridhar BT; Thimmaiah KN; Ananda Kumar CS; Shobith R; Rangappa KS
Bioorg Chem; 2021 Mar; 108():104586. PubMed ID: 33607574
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of novel soluble 2,5-diketopiperazine derivatives as potential anticancer agents.
Liao S; Qin X; Li D; Tu Z; Li J; Zhou X; Wang J; Yang B; Lin X; Liu J; Yang X; Liu Y
Eur J Med Chem; 2014 Aug; 83():236-44. PubMed ID: 24960627
[TBL] [Abstract][Full Text] [Related]
17. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
Maher M; Kassab AE; Zaher AF; Mahmoud Z
Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
[TBL] [Abstract][Full Text] [Related]
18. Non-symmetrical furan-amidines as novel leads for the treatment of cancer and malaria.
Alnabulsi S; Santina E; Russo I; Hussein B; Kadirvel M; Chadwick A; Bichenkova EV; Bryce RA; Nolan K; Demonacos C; Stratford IJ; Freeman S
Eur J Med Chem; 2016 Mar; 111():33-45. PubMed ID: 26854376
[TBL] [Abstract][Full Text] [Related]
19. Tubulin photoaffinity labeling with biotin-tagged derivatives of potent diketopiperazine antimicrotubule agents.
Yamazaki Y; Kohno K; Yasui H; Kiso Y; Akamatsu M; Nicholson B; Deyanat-Yazdi G; Neuteboom S; Potts B; Lloyd GK; Hayashi Y
Chembiochem; 2008 Dec; 9(18):3074-81. PubMed ID: 19012291
[TBL] [Abstract][Full Text] [Related]
20. Design, structure-activity relationship study and biological evaluation of the thieno[3,2-c]isoquinoline scaffold as a potential anti-cancer agent.
Liu JT; Jaunky DB; Larocque K; Chen F; Mckibbon K; Sirouspour M; Taylor S; Shafeii A; Campbell D; Braga H; Piekny A; Forgione P
Bioorg Med Chem Lett; 2021 Nov; 52():128327. PubMed ID: 34416378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
